These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 21070499)

  • 1. Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.
    Gouw SC; Van Der Bom JG; Van Den Berg HM; Zewald RA; Ploos Van Amstel JK; Mauser-Bunschoten EP
    Haemophilia; 2011 Mar; 17(2):275-81. PubMed ID: 21070499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.
    Boekhorst J; Lari GR; D'Oiron R; Costa JM; Nováková IR; Ala FA; Lavergne JM; VAN Heerde WL
    Haemophilia; 2008 Jul; 14(4):729-35. PubMed ID: 18503540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
    Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W;
    Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of inhibitor development in mild haemophilia A increases with age.
    Mauser-Bunschoten EP; Den Uijl IE; Schutgens RE; Roosendaal G; Fischer K
    Haemophilia; 2012 Mar; 18(2):263-7. PubMed ID: 21851507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment related factors and inhibitor development in children with severe haemophilia A.
    Maclean PS; Richards M; Williams M; Collins P; Liesner R; Keeling DM; Yee T; Will AM; Young D; Chalmers EA;
    Haemophilia; 2011 Mar; 17(2):282-7. PubMed ID: 21070501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.
    Goodeve AC; Williams I; Bray GL; Peake IR
    Thromb Haemost; 2000 Jun; 83(6):844-8. PubMed ID: 10896236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.
    Boekhorst J; Verbruggen B; Lavergne JM; Costa JM; Schoormans SC; Brons PP; van Kraaij MG; Nováková IR; van Heerde WL
    Br J Haematol; 2005 Oct; 131(1):109-17. PubMed ID: 16173970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of mutations in Jordanian patients with haemophilia A: identification of five novel mutations.
    Awidi A; Ramahi M; Alhattab D; Mefleh R; Dweiri M; Bsoul N; Magablah A; Arafat E; Barqawi M; Bishtawi M; Haddadeen E; Falah M; Tarawneh B; Swaidan S; Fauori S
    Haemophilia; 2010 Jan; 16(1):136-42. PubMed ID: 19817879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of F8 in Lebanese haemophilia A patients: novel mutations and phenotype-genotype correlation.
    Djambas Khayat C; Salem N; Chouery E; Corbani S; Moix I; Nicolas E; Morris MA; de Moerloose P; Mégarbané A
    Haemophilia; 2008 Jul; 14(4):709-16. PubMed ID: 18479430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.
    Coppola A; Santoro C; Tagliaferri A; Franchini M; DI Minno G
    Haemophilia; 2010 Jan; 16 Suppl 1():13-9. PubMed ID: 20059564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
    Franchini M; Girelli D; Olivieri O; Castaman G; Lippi G; Poli G; Salvagno GL; Tagariello G; Giuffrida A; de Gironcoli M; Morfini M; Berntorp E; Gandini G
    Haemophilia; 2006 Jul; 12(4):448-51. PubMed ID: 16834751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran.
    Haghpanah S; Sahraiian M; Afrasiabi A; Enayati S; Peyvandi F; Karimi M
    Haemophilia; 2011 Sep; 17(5):820-1. PubMed ID: 21371201
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions.
    Jayandharan G; Shaji RV; Baidya S; Nair SC; Chandy M; Srivastava A
    Haemophilia; 2005 Sep; 11(5):481-91. PubMed ID: 16128892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of factor VIII gene mutations in patients with severe haemophilia A in Venezuela: identification of seven novel mutations.
    Albánez S; Ruiz-Sáez A; Boadas A; de Bosch N; Porco A
    Haemophilia; 2011 Sep; 17(5):e913-8. PubMed ID: 21371196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients.
    Pinto P; Ghosh K; Shetty S
    Blood Cells Mol Dis; 2014 Sep; 53(3):161-3. PubMed ID: 24824129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large-scale computational study of inhibitor risk in non-severe haemophilia A.
    Shepherd AJ; Skelton S; Sansom CE; Gomez K; Moss DS; Hart DP
    Br J Haematol; 2015 Feb; 168(3):413-20. PubMed ID: 25244644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.
    Ivaskevicius V; Goldmann G; Horneff S; Marquardt N; Klein C; Albert T; Zeitler H; Oldenburg J
    Hamostaseologie; 2014; 34 Suppl 1():S9-12. PubMed ID: 25382774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France. Description of 62 novel mutations.
    Vinciguerra C; Zawadzki C; Dargaud Y; Pernod G; Berger C; Nougier C; Négrier C
    Thromb Haemost; 2006 Apr; 95(4):593-9. PubMed ID: 16601827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
    Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
    Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.